Related Experiment Videos

Treatment of pediatric sinusitis

Ari J Goldsmith1, Richard M Rosenfeld

  • 1Pediatric Otolaryngology, SUNY Health Sciences Center at Brooklyn, 450 Clarkson Ave., Box 126, Brooklyn, NY 11203, USA. pedsent@usa.net

Insights

Effective management of recurrent sinusitis (RS) in children involves accurate diagnosis, identifying causes, and appropriate antibiotic use. Surgery, starting with adenoidectomy, is for persistent cases, improving children's quality of life and preventing complications.

Area of Science:

  • Pediatric Otolaryngology
  • Infectious Diseases in Children
  • Respiratory Medicine

Background:

  • Recurrent sinusitis (RS) poses significant challenges in pediatric healthcare.
  • Identifying causative factors is crucial for effective treatment strategies.
  • Inadequate management can lead to chronic conditions and reduced quality of life.

Purpose of the Study:

  • To outline an optimal management approach for recurrent sinusitis in pediatric patients.
  • To emphasize the roles of diagnosis, medical therapy, and surgical interventions.
  • To highlight strategies for preventing complications and improving patient outcomes.

Main Methods:

  • Review of diagnostic criteria for pediatric RS.
  • Analysis of antibiotic stewardship principles in RS management.
  • Evaluation of surgical options, including adenoidectomy and endoscopic sinus surgery (ESS).

Main Results:

  • Accurate diagnosis and identification of etiological factors are foundational.
  • Judicious antibiotic therapy is essential for initial management.
  • Surgical intervention, prioritizing adenoidectomy, is effective for refractory RS.

Conclusions:

  • A comprehensive approach integrating diagnosis, medical, and surgical treatments optimizes RS management in children.
  • Adenoidectomy serves as a primary surgical option for refractory cases.
  • This strategy enhances quality of life and mitigates long-term complications of pediatric RS.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...